Radient does not operate.
Holding patents and trademarks does not constitute active operation. I own a couple of trademarks and one patent, for a company I don't even mention on my tax returns any more. I will maintain that intellectual property forever, because it's cheapo so why not... but that company will never operate again. That was a failed idea from my youth.
Pursuing licenses to find someone else to manufacture and market the product does not constitute operation. On the contrary, that partially DEFINES non-operation.
If you want to invest in onko-sure, buying RXPC stock is the worst way to accomplish that goal. Instead, you should invest in GCDx or UNI.
Well, UNI, maybe. I wouldn't give Gartner any money, myself.
Gartner says he needs $1.5 million to get started. Some here seem to think Gartner's LC Screener will be wildly profitable. Anyone who believes that should give Gartner money. If enough small investors pool together and give Gartner $1.5 million, he will try to sell the LC Screener online. I'd like to see that.
Today is August 1st. I want to buy the onko-sure LC Screener test from GCDx. Can I do that? No. Will I be able to do that in August 2013, or ever, for that matter? I strongly doubt that.
Gartner has no current licensing agreement to sell onko-sure. Even worse, if he DID get the funding and he starts selling the test online, I think the FDA will shut him down the way they shut down the companies selling DNA testing for ancestry websites.
News 
Market Data 
Discover 
AI
